Ten years of anti-HPV vaccinations : what do we know?

2016
journal article
article
6
cris.lastimport.wos2024-04-10T03:13:11Z
dc.abstract.enHuman papillomavirus (HPV) is one of the most important carcinogens in humans. Vaccines against HPV are now considered the first anti-cancer vaccinations. Since 2007, in many developed countries, there have been recommendations present for preventive vaccines against HPV. At present, the degree of implementation of these recommendations depends on a number of country-specific factors such as the health care system organization or the ways of funding. HPV vaccines are primarily to prevent the development of cervical cancer and other genital cancers. Therefore, only their long-term effectiveness can be measured, when a correspondingly large cohort of vaccinated teenagers reaches the age of the greatest incidence of these cancers. However, great care should be taken in assessing the results of vaccinations due to the possibility of misinterpretation and possible erroneous data. Undoubtedly, teenagers are the target population of HPV vaccines. However, vaccinating young sexually active women is also justified from an individual point of view. A 9-valent vaccine has been registered in the USA and in Europe - including Poland - as one of the three preventive vaccines. It is recommended to vaccinate women between 13 and 26 and men between 13 and 21, previously unvaccinated. It is also recommended to vaccinate men aged 26 years or less who have sexual relations with other men and people with reduced immunity, including HIV-positive people who have not been vaccinated previously.pl
dc.affiliationWydział Lekarski : Klinika Endokrynologii Ginekologicznejpl
dc.affiliationWydział Lekarski : Klinika Ginekologii i Onkologiipl
dc.cm.date2020-01-07
dc.cm.id80253
dc.contributor.authorJach, Robert - 129777 pl
dc.contributor.authorBasta, Antoni - 128692 pl
dc.contributor.authorKotarski, Janpl
dc.contributor.authorMarkowska, Janinapl
dc.contributor.authorPaszkowski, Tomaszpl
dc.contributor.authorDębski, Romualdpl
dc.contributor.authorRokita, Wojciechpl
dc.contributor.authorKędzia, Witoldpl
dc.contributor.authorKiszka, Krystynapl
dc.date.accessioned2020-01-17T09:12:06Z
dc.date.available2020-01-17T09:12:06Z
dc.date.issued2016pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number3pl
dc.description.physical170-175pl
dc.description.points8pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume15pl
dc.identifier.doi10.5114/pm.2016.63497pl
dc.identifier.eissn2299-0038pl
dc.identifier.issn1643-8876pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/139482
dc.languageengpl
dc.language.containerpolpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Na tych samych warunkach 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC-SA
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.plpl
dc.share.typeotwarte czasopismo
dc.subject.enHPVpl
dc.subject.enhuman papillomaviruspl
dc.subject.enHPV vaccinepl
dc.subtypeArticlepl
dc.titleTen years of anti-HPV vaccinations : what do we know?pl
dc.title.journalPrzegląd Menopauzalnypl
dc.typeJournalArticlepl
dspace.entity.typePublication
cris.lastimport.wos
2024-04-10T03:13:11Z
dc.abstract.enpl
Human papillomavirus (HPV) is one of the most important carcinogens in humans. Vaccines against HPV are now considered the first anti-cancer vaccinations. Since 2007, in many developed countries, there have been recommendations present for preventive vaccines against HPV. At present, the degree of implementation of these recommendations depends on a number of country-specific factors such as the health care system organization or the ways of funding. HPV vaccines are primarily to prevent the development of cervical cancer and other genital cancers. Therefore, only their long-term effectiveness can be measured, when a correspondingly large cohort of vaccinated teenagers reaches the age of the greatest incidence of these cancers. However, great care should be taken in assessing the results of vaccinations due to the possibility of misinterpretation and possible erroneous data. Undoubtedly, teenagers are the target population of HPV vaccines. However, vaccinating young sexually active women is also justified from an individual point of view. A 9-valent vaccine has been registered in the USA and in Europe - including Poland - as one of the three preventive vaccines. It is recommended to vaccinate women between 13 and 26 and men between 13 and 21, previously unvaccinated. It is also recommended to vaccinate men aged 26 years or less who have sexual relations with other men and people with reduced immunity, including HIV-positive people who have not been vaccinated previously.
dc.affiliationpl
Wydział Lekarski : Klinika Endokrynologii Ginekologicznej
dc.affiliationpl
Wydział Lekarski : Klinika Ginekologii i Onkologii
dc.cm.date
2020-01-07
dc.cm.id
80253
dc.contributor.authorpl
Jach, Robert - 129777
dc.contributor.authorpl
Basta, Antoni - 128692
dc.contributor.authorpl
Kotarski, Jan
dc.contributor.authorpl
Markowska, Janina
dc.contributor.authorpl
Paszkowski, Tomasz
dc.contributor.authorpl
Dębski, Romuald
dc.contributor.authorpl
Rokita, Wojciech
dc.contributor.authorpl
Kędzia, Witold
dc.contributor.authorpl
Kiszka, Krystyna
dc.date.accessioned
2020-01-17T09:12:06Z
dc.date.available
2020-01-17T09:12:06Z
dc.date.issuedpl
2016
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
3
dc.description.physicalpl
170-175
dc.description.pointspl
8
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
15
dc.identifier.doipl
10.5114/pm.2016.63497
dc.identifier.eissnpl
2299-0038
dc.identifier.issnpl
1643-8876
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/139482
dc.languagepl
eng
dc.language.containerpl
pol
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Na tych samych warunkach 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC-SA
dc.rights.uripl
http://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subject.enpl
HPV
dc.subject.enpl
human papillomavirus
dc.subject.enpl
HPV vaccine
dc.subtypepl
Article
dc.titlepl
Ten years of anti-HPV vaccinations : what do we know?
dc.title.journalpl
Przegląd Menopauzalny
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
16
Views per month
Views per city
Des Moines
4
Ashburn
3
Dublin
2
Wroclaw
2
Chandler
1
Szczecin
1
Downloads
jach_et-al_ten_years_of_anti-hpv_vaccinations_2016.pdf
11
jach_et-al_ten_years_of_anti-hpv_vaccinations_2016.odt
9